MTX-216, identified by its CAS number 1952236-19-9, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like MTX-216 are typically evaluated for their pharmacological properties, including efficacy, safety, and mechanism of action. It is essential to consider its stability, reactivity, and interaction with biological systems, which can influence its behavior in drug development. Additionally, the compound may exhibit specific functional groups that contribute to its biological activity. As research progresses, detailed studies will provide insights into its pharmacokinetics, pharmacodynamics, and potential side effects, which are crucial for understanding its role in therapeutic contexts. For the most accurate and comprehensive information, consulting scientific literature and databases is recommended, as ongoing research may yield new findings regarding MTX-216's characteristics and applications.

MTX-216

1952236-19-9: MTX-216, identified by its CAS number 1952236-19-9, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds like MTX-216 are typically evaluated for their pharmacological properties, including efficacy, safety, and mechanism of action. It is essential to consider its stability, reactivity, and interaction with biological systems, which can influence its behavior in drug development. Additionally, the compound may exhibit specific functional groups that contribute to its biological activity. As research progresses, detailed studies will provide insights into its pharmacokinetics, pharmacodynamics, and potential side effects, which are crucial for understanding its role in therapeutic contexts. For the most accurate and comprehensive information, consulting scientific literature and databases is recommended, as ongoing research may yield new findings regarding MTX-216's characteristics and applications.

<p>MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research.</p>

CAS 1952236-19-9

MTX-216

MTX-216

Ref: TM-T206251